PRTN3 and rheumatoid arthritis: Because of the baseline difference in ACPA positivity between the groups and because we hypothesized that an impact of treatment strategy on DMARD-free remission might be different in ACPA-positive and ACPA-negative RA patients, analyses were stratified by ACPA status.